Global Aptamers Market Size, Status and Forecast 2022

Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called “Systematic evolution of ligands by exponential enrichment” (SELEX).
Aptamers receive their name from the Latin word aptus meaning “fit”. This means they bind to the target molecules with high specificity and high affinity.
Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.
Global Aptamers key players include TriLink BioTechnologies, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies etc. The Global top 5 manufacturers hold a share about 8%.North America is the largest market, with a share about 45%, followed by Europe and China with the share about 30% and 5%.

Market Analysis and Insights: Global Aptamers Market
The global Aptamers market size is projected to reach US$ 696.5 million by 2027, from US$ 203.9 million in 2020, at a CAGR of 19.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Aptamers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Aptamers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Aptamers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Aptamers market.

Global Aptamers Scope and Market Size
Aptamers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aptamers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers

Segment by Application
Research and Development
Drug Discovery

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics